RGT 1.32% 37.5¢ argent biopharma limited

Ann: 1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL, page-5

  1. 202 Posts.
    lightbulb Created with Sketch. 146
    For the sake of the World, and a Future where Covid -will be with us forever, this wonder drug would be a Godsend.

    The only part I am concerned about -- is Most deaths seem to be a result of patients with Comorbities ( Diabiities, Hypertension, Cerebrovascular Disease, Heart Failure, CKD stage>3, Dementia etc etc..) . and from a report I just read the length of stay averaged at 21 days or with death Length of stay is 14 days..

    https://hotcopper.com.au/data/attachments/3354/3354529-5fde1eb3f0b22dd054a8e8b5a133e0aa.jpg
    As I said -- I hope this wonder drug does work...
    But HOW DO YOU RUN A TEST OVER 28 TWENTY EIGHT DAYS when the hospitalisation periods is less then average case.

    To find over 250 patients or test samples for the 28day tests --- would continue to provide an Incomplete or Inconclusive Result.

    Looks great on paper and will surely bolster the share price short term --- But is it plausable?
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
37.5¢
Change
-0.005(1.32%)
Mkt cap ! $17.20M
Open High Low Value Volume
38.0¢ 38.0¢ 37.5¢ $376 1.002K

Buyers (Bids)

No. Vol. Price($)
2 1007 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 769 4
View Market Depth
Last trade - 12.53pm 06/05/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.